Therefore, we assumed that the presence of TLR2 activates these two signaling pathways, which are then activated for the transcription of downstream inflammatory factor encoding genes, resulting in increased release of inflammatory factors, creating a microenvironment of inflammatory infiltration, and ultimately inducing the occurrence of hypertension and hyperlipidemia. This evidence concerns the gene TLR2 and hyperlipidemia.